
Cells in living organisms function in an orderly manner by cooperating with surrounding cells while interacting with extracellular proteins. However, in cell culture systems, extracellular proteins are largely absent, making it difficult for cells to function properly and often causing them to exhibit physiological activities that differ from those observed in vivo. Our company conducts research on extracellular matrix proteins located outside the cell, and by applying the findings from this research to cell culture technologies, we aim to contribute to the advancement of regenerative medicine and the realization of alternatives to animal experimentation.

A startup has developed a painless, simple test using tears to detect cancer early and monitor for recurrence. Using cutting-edge technology originating from Kobe University, it enables highly sensitive detection of extracellular vesicles, allowing testing in everyday settings like homes or pharmacies.

It is well established that drivers’ spatial cognitive abilities are closely linked to traffic accident risk. Our company is committed to advancing driver safety and extending driver retirement age by leveraging proprietary technologies that enable the quantitative assessment and targeted training of spatial cognition ability.

Our company engages in the research and development, manufacturing, and sales of diagnostic test kits, primarily focused on in vitro diagnostic (IVD) products. In the field of infectious diseases, we provide rapid diagnostic kits for tropical infectious diseases such as dengue fever. In the pre-symptomatic healthcare field, we offer testing solutions—including genetic testing and microbiological testing—for individual and corporate sales, as well as for medical and research institutions. In addition, we collaborate not only within Japan but also with overseas bases and partners, including those in Thailand, and have established a product development and supply system that complies with regulatory requirements in each country.

A brain tech company originating from Osaka University. Developed the world's first wireless implantable BCI connecting the brain to devices, realizing future healthcare where devices can be operated by thought alone. Pioneering new communication methods for people with illnesses or disabilities that make conversation or movement difficult.